Intersect Diagnostics Overview

  • Founded
  • 2019
Founded
  • Status
  • Private
  • Latest Deal Type
  • Angel
  • Latest Deal Amount
  • $75K
Latest Deal Amount

Intersect Diagnostics General Information

Description

Developer of novel biomarker signatures intended to be used in precision therapeutics. The company's technology is used in design, optimization, validation and deployment of proprietary assays on new drug development instruments, enabling medical research institutes in advancing novel therapies toward regulatory approval.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 635 Kingsbridge Lane
  • Ridgewood, NJ 07450
  • United States
+1 (201) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intersect Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 24-Mar-2020 $75K 0000 Completed Generating Revenue
To view Intersect Diagnostics’s complete valuation and funding history, request access »

Intersect Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Boaz Kurtis MD Founder, Chief Executive Officer & Board Member
Edward Sitar Outside Chief Financial Officer
To view Intersect Diagnostics’s complete executive team members history, request access »

Intersect Diagnostics Board Members (1)

Name Representing Role Since
Boaz Kurtis MD Intersect Diagnostics Founder, Chief Executive Officer & Board Member 000 0000
To view Intersect Diagnostics’s complete board members history, request access »